Hisao Ikeya

Antitumor studies. Part 1: Design, synthesis, antitumor activity, and AutoDock study of 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides as a new class of antitumor agents

Hamed I. Ali, Keiichiro Tomita, Eiichi Akaho et al. · Bioorganic & Medicinal Chemistry · 2006 · 58 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +10

Mechanism of action of aragusterol a (YTA0040), a potent anti-tumor marine steroid targeting the G1 phase of the cell cycle

Kazuya Fukuoka, Takehiro Yamagishi, Tomoko Ichihara et al. · International Journal of Cancer · 2000 · 31 citations · Full text

Medicine, Oncology, Pharmacology +13

Antitumor studies – Part 2: Structure–activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase

Hamed I. Ali, Keiichiro Tomita, Eiichi Akaho et al. · European Journal of Medicinal Chemistry · 2007 · 29 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

Lithium inhibits stress-induced changes in tau phosphorylation in the mouse hippocampus

S. Yoshida, Maoko Maeda, Shinsuke Kaku et al. · Journal of Neural Transmission · 2006 · 22 citations

Life Sciences, Neurobiology, Neuroscience +14

A novel low molecular weight antagonist of vascular endothelial growth factor receptor binding: VGA1155.

Yasuji Ueda, Takehiro Yamagishi, Kazunori Samata et al. · PubMed · 2003 · 22 citations

Medicine, Medicinal Chemistry, Pharmacology +17